Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.03%2.25B | 4.26%1.89B | -7.65%1.85B | -21.41%7.83B | -21.69%2.05B | -16.77%1.97B | -34.81%1.81B | -17.68%2B | -0.70%9.96B | -15.11%2.61B |
| Operating revenue | 14.03%2.25B | 4.26%1.89B | -7.65%1.85B | -21.41%7.83B | -21.69%2.05B | -16.77%1.97B | -34.81%1.81B | -17.68%2B | -0.70%9.96B | -15.11%2.61B |
| Cost of revenue | 11.10%1.71B | 5.57%1.49B | -1.77%1.45B | -17.37%6.06B | -16.58%1.63B | -10.97%1.54B | -32.14%1.41B | -18.15%1.48B | -2.72%7.33B | -14.76%1.95B |
| Gross profit | 24.39%541.2M | -0.40%397.7M | -24.32%394.8M | -32.67%1.77B | -36.79%417.5M | -32.33%435.1M | -42.76%399.3M | -16.33%521.7M | 5.39%2.63B | -16.14%660.5M |
| Operating expense | 22.06%335.9M | 13.99%305.5M | -7.74%291.9M | -6.07%1.13B | -17.76%271.9M | -2.45%275.2M | -14.27%268M | -3.15%316.4M | 5.83%1.2B | -7.27%330.6M |
| Selling and administrative expenses | 26.86%225.3M | 12.68%208.9M | -10.78%185.3M | -5.95%753.4M | -14.94%182.8M | 1.25%177.6M | -12.09%185.4M | -8.22%207.7M | 3.38%801.1M | -10.31%214.9M |
| -Selling and marketing expense | 12.13%123.9M | 8.49%112.4M | -7.65%107.4M | -3.58%438.4M | -2.17%108.1M | -0.90%110.5M | -11.53%103.6M | -8.78%116.3M | 4.82%454.7M | -6.20%110.5M |
| -General and administrative expense | 51.12%101.4M | 17.97%96.5M | -14.77%77.9M | -9.06%315M | -28.45%74.7M | 5.01%67.1M | -12.79%81.8M | -7.49%91.4M | 1.55%346.4M | -14.29%104.4M |
| Research and development costs | 15.05%110.1M | 21.41%96.4M | -2.96%105M | -2.69%391.1M | -5.18%107.9M | -9.03%95.7M | -22.69%79.4M | 6.39%108.2M | 9.30%401.9M | -5.95%113.8M |
| Other operating expenses | -73.68%500K | -93.75%200K | 220.00%1.6M | -912.50%-13M | -1,089.47%-18.8M | 26.67%1.9M | 420.00%3.2M | 138.46%500K | 136.36%1.6M | 146.34%1.9M |
| Operating profit | 28.39%205.3M | -29.78%92.2M | -49.88%102.9M | -55.08%642.1M | -55.87%145.6M | -55.69%159.9M | -65.90%131.3M | -30.83%205.3M | 5.01%1.43B | -23.47%329.9M |
| Net non-operating interest income (expenses) | -29.32%-64.4M | -2.39%-47.2M | 3.21%-45.3M | 0.63%-190.2M | -1.71%-47.5M | 19.02%-49.8M | -12.17%-46.1M | -9.35%-46.8M | -75.92%-191.4M | -29.72%-46.7M |
| Non-operating interest income | 146.15%3.2M | -17.50%3.3M | -27.78%1.3M | -51.81%8M | -68.97%900K | -78.69%1.3M | -34.43%4M | 20.00%1.8M | 176.67%16.6M | 107.14%2.9M |
| Non-operating interest expense | 6.07%52.4M | -1.89%46.8M | -3.88%44.6M | 5.14%190.1M | 2.87%46.6M | 7.16%49.4M | 4.15%47.7M | 6.42%46.4M | 58.32%180.8M | 13.53%45.3M |
| Total other finance cost | 794.12%15.2M | 54.17%3.7M | -9.09%2M | -70.22%8.1M | -58.14%1.8M | -92.09%1.7M | 71.43%2.4M | 214.29%2.2M | 4,433.33%27.2M | 272.00%4.3M |
| Other net income (expenses) | 26.94%-33.9M | 61.16%-8.7M | 237.79%117.4M | -818.71%-299.5M | -249.23%-145.5M | 67.84%-46.4M | -131.64%-22.4M | -46.14%-85.2M | 62.31%-32.6M | 57.26%97.5M |
| Gain on sale of security | -37.05%-34.4M | 35.07%-8.7M | 266.06%117.9M | -640.63%-213.3M | -202.47%-103.8M | 82.61%-25.1M | -118.93%-13.4M | -21.78%-71M | 66.71%-28.8M | 63.39%101.3M |
| Special income (charges) | 102.35%500K | --0 | 96.48%-500K | -2,168.42%-86.2M | -997.37%-41.7M | ---21.3M | ---9M | ---14.2M | ---3.8M | ---3.8M |
| -Less:Restructuring and mergern&acquisition | -104.20%-500K | --0 | -96.48%500K | 1,921.05%76.8M | 997.37%41.7M | --11.9M | --9M | --14.2M | --3.8M | --3.8M |
| -Less:Write off | --0 | ---- | ---- | --9.4M | --0 | --9.4M | ---- | ---- | --0 | --0 |
| Income before tax | 67.97%107M | -42.20%36.3M | 138.74%175M | -87.36%152.4M | -112.45%-47.4M | -58.93%63.7M | -84.86%62.8M | -62.54%73.3M | 3.39%1.21B | -16.71%380.7M |
| Income tax | -7.85%30.5M | -200.00%-20.8M | -54.55%14M | -67.23%89.7M | -93.58%5M | -49.08%33.1M | -72.63%20.8M | -25.24%30.8M | -8.92%273.7M | -15.33%77.9M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 911.76%68.8M | 226.39%23.5M | 2,128.38%150.1M | -128.61%-213M | -216.68%-219.6M | -89.22%6.8M | -97.87%7.2M | -104.79%-7.4M | -13.97%744.5M | -48.45%188.2M |
| Net income continuous operations | 150.00%76.5M | 35.95%57.1M | 278.82%161M | -93.27%62.7M | -117.31%-52.4M | -66.04%30.6M | -87.60%42M | -72.49%42.5M | 7.66%931.7M | -17.06%302.8M |
| Net income discontinuous operations | 67.65%-7.7M | 3.45%-33.6M | 78.16%-10.9M | -47.28%-275.7M | -45.90%-167.2M | 11.85%-23.8M | ---34.8M | ---49.9M | ---187.2M | ---114.6M |
| Noncontrolling interests | 0.00%-300K | -233.33%-800K | -150.00%-100K | -90.91%100K | -33.33%-400K | -400.00%-300K | -40.00%600K | -33.33%200K | -26.67%1.1M | -50.00%-300K |
| Net income attributable to the company | 873.24%69.1M | 268.18%24.3M | 2,076.32%150.2M | -128.67%-213.1M | -216.29%-219.2M | -88.73%7.1M | -98.05%6.6M | -104.93%-7.6M | -13.95%743.4M | -48.40%188.5M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 873.24%69.1M | 268.18%24.3M | 2,076.32%150.2M | -128.67%-213.1M | -216.29%-219.2M | -88.73%7.1M | -98.05%6.6M | -104.93%-7.6M | -13.95%743.4M | -48.40%188.5M |
| Diluted earnings per share | 944.44%0.94 | 266.67%0.33 | 2,160.00%2.06 | -130.01%-2.89 | -219.28%-2.97 | -89.02%0.09 | -97.93%0.09 | -105.10%-0.1 | -11.49%9.63 | -45.99%2.49 |
| Basic earnings per share | 944.44%0.94 | 312.50%0.33 | 2,140.00%2.04 | -130.52%-2.89 | -220.73%-2.97 | -88.89%0.09 | -98.12%0.08 | -105.21%-0.1 | -11.25%9.47 | -45.58%2.46 |
| Dividend per share | 2.38%0.215 | 2.38%0.215 | 2.38%0.215 | 16.67%0.84 | 16.67%0.21 | 16.67%0.21 | 16.67%0.21 | 16.67%0.21 | 12.50%0.72 | 12.50%0.18 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.